MedNation AG (FRA:EIF)
Germany · Delayed Price · Currency is EUR 4.020
+0.020 (0.50%)
At close: Sep 18, 2026
MedNation AG Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11 | 7 | 5 | 5 | 10 | 11 | |
Market Cap Growth | 91.43% | 62.54% | 0% | -55.62% | -10.11% | -2.59% |
Enterprise Value | 20 | 18 | 51 | 56 | 62 | 49 |
Last Close Price | 4.02 | 2.62 | 1.50 | 1.50 | 3.38 | 3.76 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 3.76 | 2.93 | 43.25 | 9.40 | - | - |
PS Ratio | 0.21 | 0.14 | 0.09 | 0.10 | 0.26 | 0.31 |
PB Ratio | 0.73 | 0.48 | 0.36 | 0.36 | 1.03 | 1.05 |
P/TBV Ratio | 0.81 | 0.53 | 0.39 | 0.39 | 1.11 | 1.14 |
P/FCF Ratio | 12.77 | 8.32 | 3.13 | 7.06 | 32.17 | 4.24 |
P/OCF Ratio | 5.10 | 3.32 | 1.96 | 4.57 | 16.80 | 3.12 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.38 | 0.34 | 1.04 | 1.24 | 1.60 | 1.34 |
EV/EBITDA Ratio | 5.76 | 5.10 | 22.70 | 24.23 | 66.59 | 45.27 |
EV/EBIT Ratio | 9.69 | 8.57 | 55.11 | 48.76 | - | - |
EV/FCF Ratio | 22.82 | 20.19 | 34.97 | 87.56 | 195.34 | 18.37 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.76 | 0.76 | 0.98 | 1.15 | 5.64 | 5.26 |
Debt / EBITDA Ratio | 3.31 | 3.31 | 5.53 | 6.33 | 18.06 | 15.82 |
Debt / FCF Ratio | 13.13 | 13.13 | 8.52 | 22.86 | 175.80 | 21.22 |
Net Debt / Equity Ratio | 0.50 | 0.50 | 0.74 | 0.82 | 5.12 | 4.68 |
Net Debt / EBITDA Ratio | 2.18 | 2.18 | 4.20 | 4.52 | 54.42 | 46.52 |
Net Debt / FCF Ratio | 8.63 | 8.63 | 6.47 | 16.33 | 159.63 | 18.88 |
Asset Turnover | 1.43 | 1.43 | 1.32 | 0.80 | 0.50 | 0.49 |
Inventory Turnover | 41.90 | 41.90 | 36.10 | 53.24 | 87.15 | 59.67 |
Quick Ratio | 3.21 | 3.21 | 2.14 | 1.91 | 0.97 | 1.14 |
Current Ratio | 3.63 | 3.63 | 2.55 | 2.33 | 1.04 | 1.23 |
Return on Equity (ROE) | 19.70% | 19.70% | 1.84% | 4.87% | -17.87% | -32.79% |
Return on Assets (ROA) | 3.52% | 3.52% | 1.55% | 1.27% | -0.27% | -0.66% |
Return on Invested Capital (ROIC) | 8.03% | 8.21% | 1.99% | 1.85% | -0.55% | -1.39% |
Return on Capital Employed (ROCE) | 6.00% | 6.00% | 2.80% | 3.40% | -0.50% | -1.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 22.26% | 34.15% | 2.31% | 10.63% | -18.51% | -38.78% |
FCF Yield | 7.83% | 12.02% | 31.99% | 14.16% | 3.11% | 23.59% |
Buyback Yield / Dilution | 16.37% | 16.37% | 6.94% | - | - | - |
Total Shareholder Return | 16.37% | 16.37% | 6.94% | - | - | - |